Cp-Il22Bp Mrna Intratumorally
Peptides
West China HospitalvaccinePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Peptides cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Adrenomedullin Danish Headache Center | N/A | D |
Amylin Danish Headache Center | N/A | D |
Same molecule, other indications
Cp-Il22Bp Mrna Intratumorally is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →